LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 201,447 Value ($000) $91 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 183,355 Value ($000) $92 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 186,898 Value ($000) $169 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 132,491 Value ($000) $132 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 115,080 Value ($000) $170 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 111,456 Value ($000) $121 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 110,975 Value ($000) $131 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 104,087 Value ($000) $147 Avg Close $1.38 Range $1.24 - $1.57
Q1 2022
Shares 101,742 Value ($000) $157 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 120,434 Value ($000) $295 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 118,723 Value ($000) $299 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 112,515 Value ($000) $321 Avg Close $2.59 Range $2.14 - $3.00
Q1 2020
Shares 180,344 Value ($000) $149 Avg Close $1.00 Range $0.58 - $1.67
Q4 2019
Shares 180,344 Value ($000) $161 Avg Close $0.83 Range $0.53 - $1.02
Q3 2019
Shares 180,201 Value ($000) $177 Avg Close $1.03 Range $0.82 - $1.26